XML 23 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Jan. 31, 2019
Jan. 31, 2018
Cash flows from operating activities:    
Net loss $ (3,331,240) $ (2,671,946)
Adjustments to reconcile net loss to net cash used in operating activities:    
Intangible impairment charge 2,500,000
Expenses paid on behalf of the Company by related party 24,300 4,000
Depreciation and amortization 37,011
Stock-based compensation 1,763,950
Changes in operating assets and liabilities:    
Accounts receivable (12,825)
Prepaid expenses 57,778 64,323
Inventories 4,133 3,915
Deposit on sales 71,225
Accounts payable and accrued expenses 280,202 6,850
Net Cash Used In Operating Activities (1,105,466) (92,858)
Cash flows from investing activities:    
Cash paid for acquisition (400,000)
Purchase of equipment (4,163)
Net Cash Provided by Investing Activities (404,163)
Cash flows from financing activities:    
Proceeds from sale of common stock 1,500,000 50,000
(Payment) proceeds from bank overdraft (762) 762
Proceeds from exercise of warrants 500,000
Proceeds from notes payable 25,000 15,000
Payment of notes payable (1,820)
Proceeds from advances of related parties 2,500 8,250
Payment of related party advances (41,030) (8,250)
Net Cash Provided by Financing Activities 1,983,888 65,762
Effect of exchange rate on cash 394 (28)
Net change in cash 474,653 (27,124)
Cash and cash equivalents - Beginning of period 27,124
Cash and cash equivalents - End of period 474,653
Cash paid for:    
Interest
Income taxes
Supplemental disclosure of non-cash investing and financing activities    
Common stock issued for services 1,763,950 222,500
Common stock issued for patents 2,500,000
Assets purchased    
Equipment 160,065
Intangibles 2,089,935
Total 2,250,000
Liabilities assumed
Net assets purchased 2,250,000
Common stock issued (1,850,000)
Cash paid $ 400,000